Fonte: Presentation program. Nome do evento: Brazil MRS Meeting. Unidade: IFSC
Assuntos: NANOPARTÍCULAS, CARCINOMA, PLANEJAMENTO DE FÁRMACOS
ABNT
RODERO, Camila Fernanda et al. Development of PLGA nanoparticles encapsulated with paclitaxel and functionalized with bevacizumab for lung carcinoma therapy. 2025, Anais.. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat, 2025. Disponível em: https://www.eventweb.com.br/xxiiisbpmat/specific-files/manuscripts/xxiiisbpmat/1506_1748314645.pdf. Acesso em: 23 nov. 2025.APA
Rodero, C. F., Martins, B. M. B., Zapata, A. M. M., & Zucolotto, V. (2025). Development of PLGA nanoparticles encapsulated with paclitaxel and functionalized with bevacizumab for lung carcinoma therapy. In Presentation program. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat. Recuperado de https://www.eventweb.com.br/xxiiisbpmat/specific-files/manuscripts/xxiiisbpmat/1506_1748314645.pdfNLM
Rodero CF, Martins BMB, Zapata AMM, Zucolotto V. Development of PLGA nanoparticles encapsulated with paclitaxel and functionalized with bevacizumab for lung carcinoma therapy [Internet]. Presentation program. 2025 ;[citado 2025 nov. 23 ] Available from: https://www.eventweb.com.br/xxiiisbpmat/specific-files/manuscripts/xxiiisbpmat/1506_1748314645.pdfVancouver
Rodero CF, Martins BMB, Zapata AMM, Zucolotto V. Development of PLGA nanoparticles encapsulated with paclitaxel and functionalized with bevacizumab for lung carcinoma therapy [Internet]. Presentation program. 2025 ;[citado 2025 nov. 23 ] Available from: https://www.eventweb.com.br/xxiiisbpmat/specific-files/manuscripts/xxiiisbpmat/1506_1748314645.pdf
